Total medical devices industry venture financing deals in April 2020 worth $418.2m were announced in the US, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 38.7% over the previous month and a drop of 35.8% when compared with the last 12-month average of $651.31m.

The US held a 46.5% share of the global medical devices industry venture financing deal value that totalled $898.52m in April 2020.

In terms of deal activity, the US recorded 47 deals during April 2020, marking an increase of 17.5% over the previous month and a drop of 23% over the 12-month average.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

The US medical devices industry venture financing deals in April 2020: Top deals

The top five medical devices industry venture financing deals accounted for 46.4% of the overall value during April 2020.

The combined value of the top five medical devices venture financing deals stood at $194m, against the overall value of $418.2m recorded for the month.

The top five medical devices industry deals of April 2020 tracked by GlobalData were:

1) Cedars-Sinai Medical Center, John Doerr and Pitango Venture Capital’s $70m venture financing of Click Diagnostics

2) The $50m venture financing of Dascena by Euclidean Capital, Frazier Healthcare Partners and Longitude Capital Management Co

3) Clinton Capital Partners, Perennial Value Management, ROTH Capital Partners and Vickers Venture Partners’ $34m venture financing of Lumitron Technologies

4) The $25m venture financing of AtaCor Medical by aMoon Partners, Broadview Ventures, Catalyst Health Ventures, Hatteras Venture Partners and Longview Ventures

5) Adjuvant Capital, Aera VC, Better Ventures, Bill & Melinda Gates Foundation, Fifty Years Fund, Ingressive Capital, KdT Ventures, Novartis, Pioneer Fund, Raba Capital, V8 Capital Partners and Y Combinator Management’s venture financing of Stack Diagnostics for $15m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.